1-methyl-3-isobutylxanthine has been researched along with Ocular Hypertension in 2 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Ocular Hypertension: A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intraocular pressure was measured at specific times after exposure." | 1.29 | Enhanced prostaglandin synthesis after ultraviolet-B exposure modulates DNA synthesis of lens epithelial cells and lowers intraocular pressure in vivo. ( Andley, UP; Becker, B; Hebert, JS; Morrison, AR; Pentland, AP; Reddan, JR, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alarma-Estrany, P | 1 |
| Crooke, A | 1 |
| Mediero, A | 1 |
| Peláez, T | 1 |
| Pintor, J | 1 |
| Andley, UP | 1 |
| Becker, B | 1 |
| Hebert, JS | 1 |
| Reddan, JR | 1 |
| Morrison, AR | 1 |
| Pentland, AP | 1 |
2 other studies available for 1-methyl-3-isobutylxanthine and Ocular Hypertension
| Article | Year |
|---|---|
Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits.
Topics: 1-Methyl-3-isobutylxanthine; Administration, Topical; Adrenergic beta-Agonists; Albuterol; Animals; | 2008 |
Enhanced prostaglandin synthesis after ultraviolet-B exposure modulates DNA synthesis of lens epithelial cells and lowers intraocular pressure in vivo.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Autoradiography; Cell Division; Cell Line; Cells, Cultured; Cy | 1996 |